Health product recall

Jardiance (2020-09-14)

Starting date:
September 14, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73947

Last updated: 2020-09-17

Summary

  • Product: Jardiance

Reason

The affected lot is out of specification (OOS) for Uniformity of Dosage Units.

Depth of distribution

Wholesalers

Affected products

Jardiance

DIN, NPN, DIN-HIM

DIN 02443945

Dosage form

Tablet

Strength

Empagliflozin 25 MG

Lot or serial number

958266

Companies

Recalling Firm
Boehringer Ingelheim (Canada) Ltd
5180 South Service Road
Burlington
L7L 5H4
Ontario
CANADA
Marketing Authorization Holder
Boehringer Ingelheim (Canada) Ltd
5180 South Service Road
Burlington
L7L 5H4
Ontario
CANADA

Date modified: